HomepageEarnings Events Newsdesk 19 hours ago Halozyme Therapeutics, Inc (HALO) U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma Halozyme Therapeutics, Inc (NASDAQ: HALO) FY 2026 Other Release Jefferies Financial Group Inc (JEF) Jefferies Comments on Western Alliance Bank Lawsuit » « Aramark (ARMK) Las Vegas A’s, Will Guidara, and Aramark Sports + Entertainment Reveal Vision for First-of-its-Kind Athletic Club Behind Home Plate of A’s New Ballpark Newsdesk: